Health (General) – Newsletter for October 30, 2010
Saturday, October 30, 2010
Haiti cholera deaths reach 330
Port-au-Prince (Haiti), Oct 30 (IANS/EFE) The number of deaths from a cholera outbreak in Haiti has reached 330, an official said.
Though the illness continues to spread, steps taken to contain it are beginning to bear fruit, said Gabriel Timothee, director-general of the health ministry.
Of the current 4,714 suspected cholera cases, only 81 patients … Read more »».
New supercharged broccoli to fight off cancer
LONDON – Brit scientists have made a major breakthrough in the fight against cancer – by unveiling a supercharged broccoli.
It comes after a 26-year slog by the scientists to cultivate a special strain of the humble veg.
Their breeding programme – started in 1984 using some wild broccoli picked in Italy – has finally come …. Source : New supercharged broccoli to fight off cancer.
Turmeric could prevent liver damage
WASHINGTON – A new Saint Louis University study has revealed that a chemical that gives curry its zing holds promise in preventing or treating liver damage from an advanced form of a condition known as fatty liver disease.
The chemical, curcurmin, is contained in turmeric, a plant used by the Chinese to make traditional medicines for …. Source article on Gaea Times at : Turmeric could prevent liver damage.
Delhi mayor down with fever, chikungunya suspected
NEW DELHI – Delhi Mayor Prithvi Raj Sawhney is down with viral fever, his son said Friday. However, a civic body leader said the doctors suspect it to be chikungunya.
“The mayor is having high fever for the past two days and the doctors suspect it to be chikungunya,” a councillor said, pleading anonymity.
…. Original article on Gaea Times at : Delhi mayor down with fever, chikungunya suspected.
63 more infected with dengue in Delhi
NEW DELHI – As many as 63 more cases of dengue were reported in the capital Friday, taking the total of people infected with the vector-born disease in Delhi this season to 5,426.
Shahdara remains the most affected area with more than 1,000 cases, said an official of the Municipal Corporation of Delhi …. Source : Gaea News Network.
Separate council, new posts for research in Siddha
NEW DELHI – The central government has created a separate council and new posts for research in the ancient Siddha medicine branch.
Central Council for Research in Siddha (CCRS) has been created as a separate body and 37 additional posts and 21 officials will be provided to focus on promoting the traditional medicine system. …. Source article : Separate council, new posts for research in Siddha.
Apex institute for communicable diseases on anvil
NEW DELHI – Worried after the outbreak of dengue and swine flu in the country, the government is to soon set up an apex institute for communicable diseases on the lines of the Centers for Disease Control and Prevention (CDC) of the United States.
The health ministry has put forward a proposal for converting …. Original article on Gaea Times at : Apex institute for communicable diseases on anvil.
One in six people at risk of stroke, say experts
NEW DELHI – One in six people around the world suffer from stroke, making it the second leading cause of death worldwide, doctors said Friday on World Stroke Day.
“The main problem is that people are not able to recognise the symptoms of stroke. If the patient is brought to hospital in time there are …. Original article : One in six people at risk of stroke, say experts.
Apex institute for communicable diseases to be set up soon
NEW DELHI – Following the outbreak of dengue, malaria and swine flu in the country in recent years, the government is planning to set up soon an apex institute for communicable diseases on the lines of the Centers for Disease Control and Prevention (CDC) of the United States.
The health ministry has put …. Source article : Apex institute for communicable diseases to be set up soon.
New drug shows promise against certain lung cancers
LONDON – A new study has shown that more than half of patients with a specific kind of lung cancer are responding positively to a treatment that targets the gene that drives their cancer.
The researchdemonstrated 57 percent of patients with ALK-positive advanced non-small cell lung cancer responded partially or completely to a tablet … Read more >>.